Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price target lowered by Guggenheim from $16.00 to $14.00 in a report published on Friday, Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also issued reports on TNGX. Barclays lowered their target price on Tango Therapeutics from $18.00 […]